ARDX
Ardelyx, Inc. · Healthcare
Chief Development Officer David P. Rosenbaum sold $141K of Ardelyx, Inc.
Sold$140,846
$9.18Price
15,344Shares
−2%Stake
What ARDX did after the filing
- The stock from Fri, Feb 9 close, $9.74
- −20.9%
- S&P 500, same days
- +4.0%
Measured over 30 trading days, to the Mar 25 close.
Traded Thu, Feb 8. Filed Fri, Feb 9, 11:14 AM ET, during the session. Returns use the Feb 9 close and the Mar 25 close. Not investment advice.